Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · IEX Real-Time Price · USD
3.995
-0.045 (-1.11%)
Jul 22, 2024, 10:29 AM EDT - Market open
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 709 employees as of December 31, 2023. The number of employees decreased by 81 or -10.25% compared to the previous year.
Employees
709
Change (1Y)
-81
Growth (1Y)
-10.25%
Revenue / Employee
$246,124
Profits / Employee
-$303,326
Market Cap
582.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
Surmodics | 376 |
Allogene Therapeutics | 233 |
ProKidney | 163 |
Annexon | 71 |
Celcuity | 55 |
Larimar Therapeutics | 42 |
ADPT News
- 10 days ago - Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024 - GlobeNewsWire
- 7 weeks ago - Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress - GlobeNewsWire
- 7 weeks ago - Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024 - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue - GlobeNewsWire
- 4 months ago - Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024 - GlobeNewsWire
- 5 months ago - Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire